Arch Pharmalabs Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1993.
1993 Mumbai, Maharashtra, India Under Cirp
Last Updated:
About Arch Pharmalabs Limited

Arch Pharmalabs Limited, a under cirp public limited company, was established on 02 April 1993 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24231MH1993PLC150891. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3,000.00 Cr and a paid-up capital of ₹156.48 Cr.

Formerly known as Sibra Pharmaceuticals Limited, Avant Papers Private Limited. It upholds a compliant status. Employing 412 professional, Its leadership includes Vikas Bijay Kedia (Company Secretary), Sunil Mansukhlal Pitroda (Director), Anshul Gupta (Irp/Rp/Liquidator). Past directors included Shantilal Dalichand Jain, Vikas Bijay Kedia, Rajiv Sarman Shukla. It holds ₹5,668.24 Cr open charges and ₹311.84 Cr settled loans. Its latest AGM occurred on 29 December 2023, with the balance sheet filed on 31 March 2023. It is based at Unit No. 301,302 And 303, H Wing 3Rd Floor, Tex Centre ,, Off Saki Vihar Road, Chandivali, Andheri East, Mumbai, Mumbai, Maharashtra, 400072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231MH1993PLC150891

  • Registration Number

    150891

  • Incorporation Date

    02 April 1993

  • Authorized Capital

    ₹3,000.00 Cr

  • Paid-Up Capital

    ₹156.48 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Under Cirp

Key Metrics
  • Authorised Capital ₹ 3,000.00 Cr
  • Paid Up Capital ₹ 156.48 Cr
  • Company Age 32 Year, 10 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 5,668.24 Cr
  • Satisfied Charges ₹ 311.84 Cr
  • Revenue Growth **** 2.29%
  • Profit Growth **** 112.30%
  • Ebitda **** 1.64%
  • Net Worth 39.39%
  • Total Assets **** 4.17%
Company report

Arch Pharmalabs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Arch Pharmalabs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Arch Pharmalabs Limited?
Current Directors
Name Designation Appointment Date Status
Vikas Bijay Kedia Company Secretary 18 Nov 2017 Current
Sunil Mansukhlal Pitroda Director 02 May 2017 Current
Anshul Gupta Irp/Rp/Liquidator 30 Apr 2025 Current
Ajit Annu Kamath Managing Director 01 Nov 2003 Current
Rajendra Padmanabhan Kaimal Whole-Time Director 01 Nov 2003 Current
Ashish Mohan Ujagare Whole-Time Director 14 Jun 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Mar 2013 Past
Pramod Abcsdd Company Secretary 30 Dec 2015 Past
Pramod Abcsdd Nominee Director 30 Nov 2009 Past
Pramod Abcsdd Additional Director 30 Sep 2011 Past
Pramod Abcsdd Nominee Director 08 Apr 2008 Past
Pramod Abcsdd Additional Director 29 Dec 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Arch Pharmalabs.

Arch Pharmalabs Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.29% increase. The company also saw a substantial improvement in profitability, with a 112.3% increase in profit. The company's net worth Soared by an impressive increase of 39.39%.

Arch Pharmalabs revenue growth over time
Arch Pharmalabs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
2.29%
*******
*******
*******
*******
Revenue from Operations
*******
2.45%
*******
*******
*******
*******
Total Assets
*******
4.17%
*******
*******
*******
*******
Profit or Loss
*******
112.30%
*******
*******
*******
*******
Net Worth
*******
39.39%
*******
*******
*******
*******
EBITDA
*******
1.64%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Arch Pharmalabs?

In 2023, Arch Pharmalabs had a promoter holding of 58.13% and a public holding of 41.87%. The company had 3 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹56,682,400,000.00

Satisfied Charges

₹3,118,437,500.00

Charges Breakdown by Lending Institutions
  • Others : 5443.74 Cr
  • Axis Trustee Services Limited : 120.00 Cr
  • Canara Bank : 50.00 Cr
  • State Bank Of Indore : 34.50 Cr
  • Standard Chartered Bank : 10.00 Cr
  • Others : 10.00 Cr
Latest Charge Details
Date Lender Amount Status
29 Mar 2022 Others ₹32.00 Cr Open
20 Jul 2021 Others ₹0.50 M Open
27 May 2021 Others ₹200.00 Cr Open
04 Dec 2017 Others ₹200.00 Cr Open
27 Sep 2013 Others ₹582.30 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Arch Pharmalabs?

Arch Pharmalabs has a workforce of 412 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Arch Pharmalabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arch Pharmalabs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Arch Pharmalabs
Recent Activity within the Organization
  • Director Appointment

    Anshul Gupta was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 30 Apr 2025 & has been associated with this company since 9 months 13 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Arch Pharmalabs Limited last Annual general meeting of members was held on 29 Dec 2023 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Arch Pharmalabs Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 32.00 Cr with Charge ID 100571158 was registered on 29 Mar 2022. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.05 Cr with Charge ID 100463954 was registered on 20 Jul 2021. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 200.00 Cr with Charge ID 100464383 was registered on 27 May 2021. was documented.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Arch Pharmalabs Limited?

The CIN of Arch Pharmalabs Limited is U24231MH1993PLC150891.

Where is Arch Pharmalabs Limited headquartered?

Arch Pharmalabs Limited is headquartered at Unit No. 301,302 And 303, H Wing 3Rd Floor, Tex Centre ,, Off Saki Vihar Road, Chandivali, Andheri East, Mumbai, Mumbai, Maharashtra, 400072.

When was Arch Pharmalabs Limited incorporated?

Arch Pharmalabs Limited was incorporated on 02 April 1993.

Who are the current directors of Arch Pharmalabs Limited?

The current directors of Arch Pharmalabs Limited are

What is the primary industry of Arch Pharmalabs Limited?

The primary industry of Arch Pharmalabs Limited is Manufacturing.

Is Arch Pharmalabs Limited a listed company?

Arch Pharmalabs Limited is unlisted.

What is the capital structure of Arch Pharmalabs Limited?

The authorized capital of Arch Pharmalabs Limited is ₹3,000.00 Cr, and the paid-up capital is ₹156.48 Cr.

What is the compliance status of Arch Pharmalabs Limited?

The compliance status of Arch Pharmalabs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available